Originally posted by PeaceOut
I think we will probably end up with about 20% of the new MedCan IPO similar to our position in AEB
Sholom has a plan and Medcan is still obviously a very important and respected partner moving forward to CGB
Does anyone else recall the other spinoff/ipo planned with one of our other new partners? dyor
Good luck and moves afoot imo
OR maybe not based on big daniels advice
MCL currently hold 15% of AEB, they will receive the remaining 4.9% after conditions are met by AEB.
'paying a further equivalent of 4.9% of the issued capital in AEB, to bring MCL to be a19.9% shareholder of AEB at that time, together with attaching options as per 3(b)above, on the date that AEB extracts oil from MCL cultivars;'
https://hotcopper.com.au/threads/an...elop-cannabis-veterinary-medications.3927926/
